Middle East & Africa Cancer Vaccines Market Size & Outlook

Name: Middle East & Africa Cancer Vaccines Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cancer vaccines market in Middle East & Africa is expected to reach a projected revenue of US$ 637.9 million by 2033. A compound annual growth rate of 5.7% is expected of Middle East & Africa cancer vaccines market from 2026 to 2033.

Pharmaceuticals
- Vaccines
  - Cancer Vaccines Market Outlook

Middle East & Africa cancer vaccines technology type outlook (Revenue, USD million, 2021-2033)
- Viral Vector and DNA Cancer Vaccines
- Other Technologies
- Recombinant Cancer Vaccines
- Whole-cell Cancer Vaccines
Middle East & Africa cancer vaccines vaccine type outlook (Revenue, USD million, 2021-2033)
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
- Other Vaccine Type
Middle East & Africa cancer vaccines indication type outlook (Revenue, USD million, 2021-2033)
- Other Indications Type
- Prostate Cancer
- Melanoma
- Cervical
- Bladder Cancer

Middle East & Africa Cancer Vaccines Market Size & Outlook

Data Tree

Sign up - it's easy, and free!